Quick answer: Sermorelin and CJC-1295 are both synthetic growth hormone-releasing hormone (GHRH) analogs studied in research models, differing primarily in their structure and described half-life; Sermorelin is a shorter GHRH fragment, while CJC-1295 is engineered for a longer-acting profile.
Sermorelin and CJC-1295 come up together constantly in growth hormone research because they are cousins in the same family. That closeness is exactly why the comparisons online tend to blur them, and most of them sneak in effect claims no research vendor should make.
Here is the honest version. We will compare Sermorelin and CJC-1295 on class, structure, and sourcing only, which is the ground a cautious buyer can stand on.
Two analogs of the same hormone
Both compounds are synthetic analogs of growth hormone releasing hormone, usually shortened to GHRH. Both are described in the literature as GHRH analogs studied for their effect on growth hormone release in research models. That shared origin is why they land in the same searches.
The split is in the design. Sermorelin is a shorter GHRH fragment analog. CJC-1295 is engineered as a long-acting GHRH analog, studied in the literature for a much longer half-life than natural GHRH. So they belong to the same class and differ in how long they are described to persist in research settings. That is the distinction most articles skip.
Sermorelin vs CJC-1295 at a glance
| Sermorelin | CJC-1295 | |
|---|---|---|
| Type | Injectable GHRH analog | Injectable GHRH analog |
| Research class | Growth hormone releasing hormone analog | Growth hormone releasing hormone analog |
| Structure | Shorter GHRH fragment analog | Long-acting GHRH analog |
| Documentation to demand | Per-batch COA, HPLC, mass spec | Per-batch COA, HPLC, mass spec |
None of that speaks to what either compound does in a person. The framing here is research-use-only, drawn from how the compounds are described in laboratory and animal models, not confirmed in humans.
Where each one sits in the literature
CJC-1295 is studied for its long-acting profile within the GHRH family. For a closer look at that compound on its own, see our what is CJC-1295 overview.
Sermorelin is often studied next to other GHRH analogs, and one common pairing is against tesamorelin. Our tesamorelin vs sermorelin breakdown covers that comparison and puts sermorelin in context within its class.
Sourcing either one
Here is where a lot of buyers get burned. Both compounds are popular, and popular compounds attract sellers who skip the testing. The comparison that should decide your purchase is not effect against effect. It is paperwork against paperwork.
For each compound, demand a per-batch Certificate of Analysis you can read before you buy, HPLC verified purity of ninety nine percent or higher on the specific lot, mass spectrometry confirmation, and a lot number tied to your vial.
Peptide Hackers carries both sermorelin and CJC-1295 with that documentation on every batch, third-party tested through Janoshik. You can see a live Certificate of Analysis before you order, then pick up the same day in Los Angeles or Newport Beach or have it shipped.
Compare the compounds all you want. Then compare the COAs, because that is the number that follows the vial home.
All products are for laboratory research only. Not for human or veterinary use.
Research Use Only
This article is provided for educational purposes. All peptides discussed are sold for research use only and are not intended for human consumption or therapeutic use.